Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1982 1
1984 1
1987 1
1988 2
1989 2
1990 1
1992 1
1993 2
1996 2
1997 2
1998 1
1999 1
2000 1
2001 3
2003 1
2005 2
2006 1
2012 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Clodronate.
Kanis JA, McCloskey EV. Kanis JA, et al. Cancer. 1997 Oct 15;80(8 Suppl):1691-5. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1691::aid-cncr21>3.3.co;2-3. Cancer. 1997. PMID: 9362438 Review.
These studies have raised the possibility that bone disease might be prevented in individuals at high risk. Double blind prospective studies in women with recurrent breast carcinoma but no evidence of skeletal metastases showed a small effect of clodronate in …
These studies have raised the possibility that bone disease might be prevented in individuals at high risk. Double blind prospective studies …
Prediction of early and late recurrence in patients with breast carcinoma.
Takeuchi H, Tsuji K, Ueo H. Takeuchi H, et al. Breast Cancer. 2005;12(3):161-5. doi: 10.2325/jbcs.12.161. Breast Cancer. 2005. PMID: 16110285 Free article.
BACKGROUND: The clinical course of patients with recurrent breast carcinoma varies greatly. Better characterization of an individual's clinical course for recurrent patients may aid in their clinical management. ...The combined analysis of these independent f …
BACKGROUND: The clinical course of patients with recurrent breast carcinoma varies greatly. Better characterization of …
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Manohar K, et al. Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716. Nucl Med Commun. 2012. PMID: 22334135
PURPOSE: Although initial studies have shown the utility of fluorine-18 fluorodeoxyglucose (F-18 FDG) PET in the detection and restaging of recurrent breast carcinoma, scarce literature exists on F-18 FDG PET/computed tomography (CT). This retrospective study …
PURPOSE: Although initial studies have shown the utility of fluorine-18 fluorodeoxyglucose (F-18 FDG) PET in the detection and restaging of …
Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y, Miyoshi Y, Taguchi T, Noguchi S. Takamura Y, et al. Cancer. 2001 Jul 15;92(2):232-9. doi: 10.1002/1097-0142(20010715)92:2<232::aid-cncr1314>3.0.co;2-g. Cancer. 2001. PMID: 11466674
Positive predictive value, negative predictive value, and diagnostic accuracy of T/N(d) ratios (81.0%, 96.0%, and 89.1%, respectively) were higher, although statistically not significant, than those of T/N(e) ratios (73.3%, 77.4%, and 76.1%, respectively), and these …
Positive predictive value, negative predictive value, and diagnostic accuracy of T/N(d) ratios (81.0%, 96.0%, and 89.1%, respe …
Fine-needle aspiration cytodiagnosis of recurrent carcinoma of the breast in operative scars.
Gupta RK. Gupta RK. Diagn Cytopathol. 1997 Jan;16(1):14-6. doi: 10.1002/(sici)1097-0339(199701)16:1<14::aid-dc4>3.0.co;2-v. Diagn Cytopathol. 1997. PMID: 9034730
In all the six suspicious cases, a subsequent biopsy confirmed a recurrent breast carcinoma. The remaining 52 cases on repeated FNAC were diagnosed as benign, and this was confirmed on a subsequent biopsy. The sensitivity, specificity, and predictive v …
In all the six suspicious cases, a subsequent biopsy confirmed a recurrent breast carcinoma. The remaining 52 cases on …
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S. Rosen PR, et al. J Clin Oncol. 1989 Mar;7(3):355-66. doi: 10.1200/JCO.1989.7.3.355. J Clin Oncol. 1989. PMID: 2918331
This study was undertaken to investigate the long-term survival and the probability of "cure" in a group of 644 patients treated by mastectomy for T1 breast carcinoma. After a median follow-up of 18.2 years, 23% were dead of recurrent breast carcinoma, 3% wer …
This study was undertaken to investigate the long-term survival and the probability of "cure" in a group of 644 patients treated by mastecto …
Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: prognostic factors in 196 tumors.
Lee HK, Antell AG, Perez CA, Straube WL, Ramachandran G, Myerson RJ, Emami B, Molmenti EP, Buckner A, Lockett MA. Lee HK, et al. Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):365-75. doi: 10.1016/s0360-3016(97)00740-2. Int J Radiat Oncol Biol Phys. 1998. PMID: 9457823
METHODS AND MATERIALS: From 1977 to 1990, 196 subcutaneous/superficial lesions (179 measurable, 17 microscopic) in 151 patients with recurrent breast carcinoma of the chest wall were treated with superficial 915-MHz microwave hyperthermia and irradiation. ... …
METHODS AND MATERIALS: From 1977 to 1990, 196 subcutaneous/superficial lesions (179 measurable, 17 microscopic) in 151 patients with recu …
Prediction of survival from first recurrence of breast carcinoma in Japanese women.
Takeuchi H, Ueo H, Tsuji K, Tokunaga E, Baba H, Maehara Y. Takeuchi H, et al. Breast. 2006 Apr;15(2):226-31. doi: 10.1016/j.breast.2005.03.001. Epub 2005 Jul 7. Breast. 2006. PMID: 16005234
The clinical courses of patients with recurrent breast carcinoma vary greatly. We retrospectively examined data on 1863 Japanese patients treated for a breast carcinoma from 1981 to 2000. ...Based on multivariate analysis, the four factors that were most p …
The clinical courses of patients with recurrent breast carcinoma vary greatly. We retrospectively examined data on 1863 …
Ablative procedures in patients with metastatic breast carcinoma.
Wells SA Jr, Santen RJ. Wells SA Jr, et al. Cancer. 1984 Feb 1;53(3 Suppl):762-5. doi: 10.1002/1097-0142(19840201)53:3+<762::aid-cncr2820531326>3.0.co;2-w. Cancer. 1984. PMID: 6362827 Clinical Trial.
The ability to determine the content of sex steroid receptors in breast carcinoma cells has markedly enhanced the clinician's ability to predict the response to hormonal therapy in patients with metastatic breast carcinoma. ...Currently, however, only oophorectomy is emplo …
The ability to determine the content of sex steroid receptors in breast carcinoma cells has markedly enhanced the clinician's ability to …
Serum UDP-galactosyl transferase as a potential biomarker for breast carcinoma.
Paone JF, Waalkes TP, Baker RR, Shaper JH. Paone JF, et al. J Surg Oncol. 1980;15(1):59-66. doi: 10.1002/jso.2930150110. J Surg Oncol. 1980. PMID: 6775160
In this study, GT levels were measured in randomized serum samples obtained from normal controls (group I, n = 49), patients with benign breast disease (group II, n = 46), disease controls (group III, n = 50), patients with primary breast carcinoma (group IV, n = 53), and untreat …
In this study, GT levels were measured in randomized serum samples obtained from normal controls (group I, n = 49), patients with benign bre …
28 results